Regulation of T-cell function and autoimmune inflammation by deubiquitinase CYLD
去泛素酶 CYLD 对 T 细胞功能和自身免疫炎症的调节
基本信息
- 批准号:8046495
- 负责人:
- 金额:$ 39.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:Adoptive TransferAnimal ModelAntigensAttenuatedAutoimmune ProcessAutoimmunityBiochemicalBone MarrowCD4 Positive T LymphocytesCell physiologyCellsChronicColitisComplicationCoupledDataDeubiquitinationDevelopmentDiseaseEnteralEnvironmental Risk FactorEventExperimental Autoimmune EncephalomyelitisFundingGene Expression RegulationGeneticHomeostasisHumanITGAM geneImmune System DiseasesImmune responseInfectionInflammationInflammatoryInflammatory Bowel DiseasesInflammatory disease of the intestineIntestinesKnock-outKnockout MiceKnowledgeLaboratoriesLeadLinkLymphocyteLysineMediatingMicrobeMolecularMusNF-kappa BNormal tissue morphologyOsteoclastsOsteopeniaOsteoporosisPatientsPhosphotransferasesPopulationProductionPublishingRag1 MouseRegulationRegulatory T-LymphocyteResearch Project GrantsRoleSeminalSignal TransductionSpleenT cell differentiationT cell responseT memory cellT-Cell ActivationT-LymphocyteTh1 CellsUbiquitinUbiquitinationWorkattenuationbasebonebone losscytokinedesignexperiencemacrophagemicrobialosteoclastogenesispreventpublic health relevanceresponsetherapy designtranscription factorubiquitin ligaseubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant): T cells effectively respond to foreign antigens but are tolerant to self-tissues and normal enteric flora. Inappropriate activation or differentiation of T cells can lead to severe immunological disorders, including autoimmunity and inflammation. Thus, a better understanding of the molecular mechanisms regulating T-cell activation and tolerance is important for rational design of therapies for immunological diseases. The overall objective of this application is to understand the molecular and cellular mechanisms by which a newly identified deubiquitinase (DUB), CYLD, regulates T-cell function and autoimmune inflammation. During the current funding period, we have made seminal findings that establish CYLD as a pivotal regulator of T-cell activation and autoimmune inflammation. CYLD-deficient T cells are hyper-responsive to TCR stimulation, and the CYLD knockout (CYLD-/-) mice spontaneously develop intestinal inflammation with major features of human inflammatory bowel disease (IBD). The CYLD-/- mice also experience severe bone loss, which is known as a major extra-intestinal complication of IBD and animal model of colitis. Moreover, our preliminary studies reveal that loss of CYLD renders mice hypersensitive to the induction of experimental autoimmune encephalomyelitis (EAE). Thus, CYLD is a master regulator of T-cell function and autoimmune inflammatory diseases. The studies proposed in this continuation application are based on strong preliminary and published data from our laboratory. In particular, we have shown that loss of CYLD in T cells causes constitutive activation of NF-kB, a transcription factor mediating T-cell activation and survival and being involved in many inflammatory disorders. The CYLD-/- T cells also display marked attenuation of the costimulatory molecule ICOS, which is crucial for the induction of T-cell tolerance and regulation of T-cell differentiation. Consistent with these molecular studies, we have found that the CYLD-/- T cells appear to be defective in tolerance to enteric microbes, since their adoptive transfer into lymphocyte-deficient Rag1-/- mice induces severe colitis. Furthermore, the CYLD-/- mice produce aberrantly high levels of inflammatory Th17 and Th1 cells, coupled with heightened EAE response. We have obtained preliminary evidence that CYLD regulates macrophage response to TLR-stimulated expression of a specific subset of cytokines known to regulate Th1 and Th17 differentiation. Based on these findings, we hypothesize that CYLD regulates key signaling events involved in T-cell activation and differentiation as well as tolerance induction. We will perform three specific aims to accomplish our overall objective. (1) Examine the molecular mechanism and functional significance of CYLD-mediated NF-kB regulation in T cells. (2) Characterize the molecular and cellular mechanisms by which CYLD regulate T-cell tolerance and inflammatory T-cell differentiation. (3) Examine the immunological and osteoclast-intrinsic mechanisms by which CYLD regulates bone erosion.
PUBLIC HEALTH RELEVANCE: T cells are vital for immune responses against microbial infections. However, deregulated T cell activation, due to genetic or environmental factors, can lead to severe immunological disorders, including autoimmunity and chronic inflammation. The focus of this research project is to understand how a deubiquitinase, CYLD, regulates T-cell activation and tolerance, thereby preventing the development of autoimmunity and inflammation. This knowledge is important for rational design of effective immunological therapies.
描述(申请人提供):T细胞对外来抗原有效反应,但对自身组织和正常肠道菌群有耐受性。T细胞的不适当激活或分化可导致严重的免疫紊乱,包括自身免疫和炎症。因此,更好地了解调节T细胞活化和耐受的分子机制对于合理设计免疫性疾病的治疗方法是非常重要的。这项应用的总体目标是了解一种新发现的脱泛素酶(DUB),CyLD,通过其调节T细胞功能和自身免疫性炎症的分子和细胞机制。在目前的资助期间,我们已经取得了开创性的发现,确立了CyLD是T细胞激活和自身免疫性炎症的关键调节因子。CyLD缺陷的T细胞对TCR刺激反应强烈,CyLD基因敲除(CyLD-/-)小鼠会自发发生肠道炎症,这是人类炎症性肠病(IBD)的主要特征。CyLD-/-小鼠还经历了严重的骨丢失,这是IBD的主要肠道外并发症和结肠炎的动物模型。此外,我们的初步研究表明,CyLD的丢失使小鼠对实验性自身免疫性脑脊髓炎(EAE)的诱导高度敏感。因此,CyLD是T细胞功能和自身免疫性炎症性疾病的主要调节因子。本次继续申请中提出的研究是基于我们实验室强大的初步和已发表的数据。特别是,我们已经证明,T细胞中CyLD的丢失会导致核因子-kB的结构性激活,核因子-kB是一种转录因子,介导T细胞的激活和存活,并参与许多炎症性疾病。CyLD-/-T细胞还表现出显著的共刺激分子ICOS的减弱,ICOS对于诱导T细胞耐受和调节T细胞分化至关重要。与这些分子研究一致,我们发现CyLD-/-T细胞对肠道微生物的耐受性似乎存在缺陷,因为它们过继转移到淋巴细胞缺陷的Rag1/-小鼠会导致严重的结肠炎。此外,CyLD-/-小鼠产生异常高水平的炎性Th17和Th1细胞,伴随着EAE反应的增强。我们已获得初步证据表明,CyLD调节巨噬细胞对TLR刺激的特定细胞因子亚群表达的反应,已知的细胞因子亚集调节Th1和Th17的分化。基于这些发现,我们假设CyLD调控与T细胞激活和分化以及耐受诱导有关的关键信号事件。我们将落实三个具体目标,实现总目标。(1)探讨CyLD介导的T细胞内NF-kB调控的分子机制及其功能意义。(2)研究CyLD调节T细胞耐受和炎性T细胞分化的分子和细胞机制。(3)探讨CyLD调节骨质侵蚀的免疫学和破骨细胞内在机制。
公共卫生相关性:T细胞对于针对微生物感染的免疫反应至关重要。然而,由于遗传或环境因素而导致的T细胞失控激活,可能会导致严重的免疫紊乱,包括自身免疫和慢性炎症。这项研究的重点是了解脱泛素酶CyLD如何调节T细胞的激活和耐受,从而防止自身免疫和炎症的发展。这些知识对于合理设计有效的免疫疗法是很重要的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shao-Cong Sun其他文献
Shao-Cong Sun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shao-Cong Sun', 18)}}的其他基金
Molecular mechanisms underlying immunosuppression and inflammation caused by SARS-CoV2 proteins
SARS-CoV2蛋白引起免疫抑制和炎症的分子机制
- 批准号:
10163402 - 财政年份:2020
- 资助金额:
$ 39.11万 - 项目类别:
Molecular mechanisms regulating TLR signaling and inflammation
调节 TLR 信号传导和炎症的分子机制
- 批准号:
10265710 - 财政年份:2020
- 资助金额:
$ 39.11万 - 项目类别:
Signaling functions of Peli family of E3 ubiquitin ligases
E3 泛素连接酶 Peli 家族的信号传导功能
- 批准号:
8660625 - 财政年份:2013
- 资助金额:
$ 39.11万 - 项目类别:
Signaling functions of Peli family of E3 ubiquitin ligases
E3 泛素连接酶 Peli 家族的信号传导功能
- 批准号:
9044725 - 财政年份:2013
- 资助金额:
$ 39.11万 - 项目类别:
Signaling functions of Peli family of E3 ubiquitin ligases
E3 泛素连接酶 Peli 家族的信号传导功能
- 批准号:
8469642 - 财政年份:2013
- 资助金额:
$ 39.11万 - 项目类别:
Molecular Mechanisms Regulating Noncanonical NF-kB Signaling
调节非典型 NF-kB 信号传导的分子机制
- 批准号:
7807470 - 财政年份:2009
- 资助金额:
$ 39.11万 - 项目类别:
Signaling Functions of the Tumor Suppressor CYLD
肿瘤抑制因子 CYLD 的信号传导功能
- 批准号:
7150300 - 财政年份:2006
- 资助金额:
$ 39.11万 - 项目类别:
Signaling Functions of the Tumor Suppressor CYLD
肿瘤抑制因子 CYLD 的信号传导功能
- 批准号:
7247127 - 财政年份:2006
- 资助金额:
$ 39.11万 - 项目类别:
Regulation of T-cell function and autoimmune inflammation by deubiquitinase CYLD
去泛素酶 CYLD 对 T 细胞功能和自身免疫炎症的调节
- 批准号:
8289618 - 财政年份:2006
- 资助金额:
$ 39.11万 - 项目类别:
Signaling Functions of the Tumor Suppressor CYLD
肿瘤抑制因子 CYLD 的信号传导功能
- 批准号:
7493501 - 财政年份:2006
- 资助金额:
$ 39.11万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 39.11万 - 项目类别:
Grant-in-Aid for Early-Career Scientists